key: cord-0908714-euhw61ku
authors: Ngere, I.; Munyua, P.; Harcourt, J.; Hunsperger, E.; Thornburg, N.; Muturi, M.; Osoro, E.; Gachohi, J.; Bodha, B.; Okotu, B.; Oyugi, J.; Jaoko, W.; Mwatondo, A.; Njenga, K.; Widdowson, M. A.
title: High MERS-CoV seropositivity associated with camel herd profile, husbandry practices and household socio-demographic characteristics in Northern Kenya
date: 2020-12-01
journal: Epidemiology and infection
DOI: 10.1017/s0950268820002939
sha: 52c90dc67877c47f5f910881cf6b02d7dbfabb37
doc_id: 908714
cord_uid: euhw61ku

Despite high exposure to Middle East respiratory syndrome coronavirus (MERS-CoV), the predictors for seropositivity in the context of husbandry practices for camels in Eastern Africa are not well understood. We conducted a cross-sectional survey to describe the camel herd profile and determine the factors associated with MERS-CoV seropositivity in Northern Kenya. We enrolled 29 camel-owning households and administered questionnaires to collect herd and household data. Serum samples collected from 493 randomly selected camels were tested for anti-MERS-CoV antibodies using a microneutralisation assay, and regression analysis used to correlate herd and household characteristics with camel seropositivity. Households reared camels (median = 23 camels and IQR 16–56), and at least one other livestock species in two distinct herds; a home herd kept near homesteads, and a range/fora herd that resided far from the homestead. The overall MERS-CoV IgG seropositivity was 76.3%, with no statistically significant difference between home and fora herds. Significant predictors for seropositivity (P ⩽ 0.05) included camels 6–10 years old (aOR 2.3, 95% CI 1.0–5.2), herds with ⩾25 camels (aOR 2.0, 95% CI 1.2–3.4) and camels from Gabra community (aOR 2.3, 95% CI 1.2–4.2). These results suggest high levels of virus transmission among camels, with potential for human infection.

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic respiratory infection that is endemic in dromedary camels (Camelus dromedarius) and causes asymptomatic or mild-to-severe illness in the human population. Evidence supporting camels as the primary reservoir includes isolation of the virus, the high prevalence of MERS-CoV antibodies in camel sera from many countries in the Middle East, Africa and Asia, and the ability to be experimentally infected with the virus [1] [2] [3] [4] [5] . Since 2012, when the first human case of MERS-CoV was detected in Saudi Arabia, there have been 2494 confirmed human cases and 858 deaths reported from 27 countries, including the Middle East, Southeast Asia, Europe, North America and North Africa [6, 7] . Interestingly, despite the high prevalence of MERS-CoV in camels in sub-Saharan Africa and human contact with camels and camel products, no transmission events from camels to humans have been identified in the region [8, 9] .

Human-to-human transmission of MERS-CoV can occur with close contact, with over half of the confirmed human cases worldwide occurring in healthcare settings [10] . However, human-to-human transmissions, associated with casual contact, or household settings are rare [11, 12] . Thus, camel-to-human transmission is generally considered an important pathway as supported by the geographical linking of genetically similar camel and human MERS-CoV isolates [3] . While the exact mechanism of primary MERS-CoV infection to humans from camels remains poorly understood, viral genomic studies suggest much higher rates of camel-to-human than human-to-human virus migration [13] . The MERS-CoV infection in humans causes severe respiratory illness and death in up to 35% of cases, while infection in camels is usually sub-clinical with occasional cases of mild rhinitis [14] . The two other coronaviruses that cause clinical illness in humans, including severe acute respiratory syndrome coronavirus 1 and 2 (SARS-CoV-1 and SARS-CoV-2) which are also zoonotic, have caused some of the most devastating pandemics and epidemics in human history [15, 16] .

In the camel population, MERS-CoV appears to spread efficiently, with over 70% seroprevalence reported among camels in Kenya and other parts of the world [17] [18] [19] . A longitudinal study in Egypt reported the virus spread to >90% of a herd within 2 months, followed by a rapid decline in antibodies following the end of the outbreak to suggest that multiple re-infections of herds can occur within a short period [18] . Younger camels are particularly susceptible to MERS-CoV infection when compared with older ones, shed more virus and could drive infections in camel herds [20] . The Horn of Africa, including Kenya, Sudan, Ethiopia and Somalia, is home to over 70% of the global dromedary camels population, and camel movement from the region to the Arabian Peninsula exceeds 300 000 animals every year through trade [21, 22] . Studies showed that camels imported from the Horn of Africa had higher MERS-CoV prevalence than Arabian peninsula camels, suggesting that importations played a role in the introduction and maintenance of the virus in the Arabian peninsula [18, 23] . Because of this, the spread of MERS-CoV has threatened camel trade, which is a major source of livelihood for the nomadic pastoralists in the Horn of Africa [24] . Currently, there are no drugs or vaccines for the management of MERS-CoV infections in humans or camels, although several molecules and treatments are currently being trialled for the human disease [25] .

A limited number of cross-sectional surveys have shown mixed results of MERS-CoV seropositivity [2, 19, [26] [27] [28] ; however, the determinants of these variations in seropositivity among camel-keeping communities in Kenya have not been fully elucidated [18, 27] . Here, we describe the herd profile and determinants of MERS-CoV seropositivity among camels owned by the nomadic pastoralist communities living in Northern Kenya.

Study site and setting Figure 1 shows the location of Marsabit County in Northern Kenya with camel sampling sites (red dots) in homesteads, grazing fields and watering points. Marsabit County is the largest county in Kenya, located in the sparsely populated arid regions of the country. The county is mainly inhabited by nomadic pastoralists from the Gabra, Borana and Rendille communities living in Manyattas (traditional villages) in geographically defined regions. The study was conducted in Marsabit central, in areas inhabited by the three communities. Most households in these communities keep livestock including cattle, goats, sheep, donkeys and chicken, and over 60% of the households own camels [30] .

We carried out a cross-sectional study in July-August 2018, immediately following the long rainy season. We estimated a minimum sample size of camels (n) using the formula n = (1.96) 2 p(1 − p)/d 2 , with a margin error (d ) of 0.05 at 95% confidence level [31] . We assumed a seroprevalence ( p) of 70% based on previous studies [27] and a design effect of 1.5 to account for cluster sampling. Through participatory epidemiology approaches such as mapping of human settlement and livestock movement patterns with camel farmers in the study area and informant interviews with community leaders, we identified and enlisted 29 camel-owning households living in nine settlements/ villages for inclusion in the study (Supplementary Table S1 ). Herd owners or their representatives were provided with information about the study and then interviewed upon consenting. Owing to the nomadic lifestyle of the households, sampling of camels in each settlement was concluded in one day. On the day of sampling, the number of camels in each of the nine settlements was estimated through participatory consultations with camel owners and herders. A sampling interval (I) was computed by dividing the estimated population of camels for each settlement by the daily target of 54 camels. A systematic random sampling approach was adopted whereby the first camel was identified by drawing a random number between one and I, then successive I th camels were identified and sampled in each herd until the household proportion was met. The number of camels sampled in each household in the settlement was proportional to the size of the household's camel herd. Since some households owned more than one camel herd, only the herds found near the settlement/village at the time of visit were sampled.

After adequately restraining the camels, 10 ml of blood was collected from the jugular vein into a plain vacutainer tube (BD Vacutainer®, product 366430). Samples were labelled and transported in frozen ice packs at +4°C from the field to the laboratory at Marsabit veterinary department for processing. Clotted samples were centrifuged at 2795 g for 6 min and extracted sera aliquoted into two 1.8 ml barcoded cryovial tubes (Thermofisher Scientific TM product 375418) followed by storage at −20°C in the field before being transferred to −80°C freezer in Kenya Medical Research Institute/Centers for Global Health Research (KEMRI-CGRH) laboratories in Nairobi for long-term storage. One aliquot was shipped to the CDC Respiratory Virus Immunology Laboratory in Atlanta, USA, for testing of MERS-CoV IgG antibodies using a microneutralisation assay (MNT).

Prior to testing, samples were γ irradiated by exposure to 5 × 10 6 rad of 60 Co, to inactivate potential pathogenic contaminants, and then heat-inactivated at 56°C for 30 min. MERS-CoV MNT was performed following biosafety level-3 precautions using a clinical isolate of MERS-CoV (Hu/Jordan-N3/2012) provided by the Jordan Ministry of Health and Naval Medical Research Unit 3 (Cairo, Egypt) [32, 33] . Vero cells (ATCC CCL-81) were prepared at 2 × 10 5 cells/ml in DMEM (Life Technologies, product 11965118) + 10% foetal bovine serum (Hyclone) and incubated at 37°C and 5% CO 2 until a confluency of 85-95% was achieved. In a 96-well flat-bottom plate, sera were diluted to a final concentration of 1:20 in serum-free DMEM including 1× penicillinstreptomycin (Gibco Life Technologies, product 15140122) to a final volume of 50 μl. The virus was diluted to a final working dilution of 200 TCID 50 /ml in serum-free cell culture media, and 50 μl added to each well. Following 30 min incubation at 37°C and 5% CO 2 , Vero cells were added to each well at a final concentration of 2 × 10 4 cells/well. After 5 days further incubation, cell 2 I. Ngere et al.

culture plates were fixed, stained and scored. In a level-3 biosafety cabinet, media was aspirated from wells, and 150 μl crystal violet fixative (0.15% crystal violet, 2.5% ethanol, 11% formaldehyde, 50% PBS, 0.01 M pH 7.4) added to each well. Plates were incubated in a biosafety cabinet for 20 min at 20-22°C. Fixative was aspirated, plates washed and scored. Each serum specimen was tested in triplicate and was considered positive for MERS-CoV antibodies if at least two of three replicate wells were protected against virus infection (specimen had to remain completely purple following staining with crystal violet). A 1:20 dilution was used as a lower limit of detection for positive results. Positive and negative control sera from previously tested camels were used in each MNT as described previously [33, 34] . At 1:20, all three wells of negative controls remained negative, and positive controls remained positive.

Trained research assistants used a structured questionnaire preloaded into Android® tablets running the RedCap® data collection platform to collect data on household socio-demographic information, geographic location, livestock herd structure, camel production and camel herd management information. Data analysis was carried out using R statistical software, version 3.3.3 (R Core Team, 2013). Mean or median values were computed for continuous variables and reported where appropriate after an independent assessment of normality using visual inspection and Shapiro-Wilk's test. Proportions and their 95% confidence intervals (CIs) were computed and reported for categorical variables. Analysis of the determinants of seropositivity was carried out at individual camel and herd levels to determine the association between MERS-CoV seropositivity and individual camel factors, herd structure and husbandry practices, and household socio-demographic factors in univariate and multivariate analysis. The χ 2 test was performed for categorical data and odds ratios (ORs) with corresponding 95% CIs calculated while adjusting for intra-herd clustering and number of camels sampled in each herd (herd unique ID included as a random effect). A P-value of <0.05 was considered significant. Significant predictors with P-value ⩽0.1 in the univariate analysis were selected and included in the multivariate model in a stepwise process through forward and backward selection while adjusting for herd clustering (herd unique ID as a random effect). We first constructed a full model with all variables selected from the univariate analyses and proceeded to drop those with P > 0.05 based on Wald's χ 2 test. We then sequentially re-introduced the dropped variables (smallest P-values first) and retained them in the model only if the P-value remained ⩽0.05. The 95% CIs were computed for the adjusted OR with a P-value of <0.05 considered significant in the final model.

We enrolled a total of 29 herd owners, each representing a household, of which 44.8% (n = 13) were from the Borana community and 27.6% (n = 8) each from Gabra and Rendille communities. All respondents were male, median age of 44 years (IQR 35.52) and 75.9% (n = 22) had no formal education. The median size of households was 10 persons (IQR 6-11) and 82.7% (n = 24) reported an average monthly income of US$100 or more (Table 1) .

Camel herd profile, herd dynamics and herding practices in Marsabit County Table S3 ). Camel-owning households reared their camels either in a home herd (n = 8), a range (or fora) herd (n = 13) or in both home and range herds (n = 8). The home herd was comprised of lactating female camels, dams in late pregnancy and calves of both sexes <1 year of age (median herd size = 4, IQR 0-37). This herd was maintained closer to the homestead with access to nearby water sources and pastures and attended to by young boys or older members of the household. The home herd was the milking herd, providing milk for domestic consumption and sale. The fora herds, which comprised of male calves >1 year of age and non-pregnant or non-lactating dams, were larger (median size = 20, IQR 10-63 and P < 0.01), and migrated up to 150 km from home in search of water and pastures. Older boys and hired herders looked after the fora herd. The home and fora herds were reunited at the homestead during the rainy season when pastures were plenty, and during a biennial traditional community celebration referred to as the Sorrio ceremony. The Sorrio ceremony, observed for 3 weeks by all the three communities of Marsabit, follows the lunar calendar and involves slaughtering and sharing of camel meat, smearing of camel blood as a mark of communal blessing, and free mixing of home and fora herds of the entire village. (Fig. 2) . The distribution of seropositivity by camel age, sex, and household and herd characteristics is as shown in Table 3 . Although the mean age of sampled camels was 7.4 years (S.D. = 4.8), seropositive camels were older (mean age 7.9 years, S.D. = 4.5 and P-value <0.001), when compared to seronegative camels (mean age = 5.9, S.D. = 5.7). On univariate analysis, seropositivity significantly varied by age categories, sex, respondents ethnic background, average household monthly income and camel herd sizes. Camel age was found to be a significant predictor of camel-level seropositivity (P < 0.05) with more camels aged 6-10 years old (OR 3.0, 95% CI 1.3-6.9) and 11-15 years old (OR 3.5, 95% CI 1.2-10.0) being exposed than younger camels aged 1-2 years (OR 0.2, 95% CI 0.1-0.6) when compared to camels aged 16 or more years. Similarly, female camels (when compared to males), camels from Gabra and Rendille households (compared to Borana households), camels from large herds (⩾25 camels) and camels from households with low monthly income (below US$100) had significantly increased risk of being seropositive (Table 3) .

Seven factors that had P-values ⩽0.1 were included in the multivariate model, while adjusting for herd clustering. The model identified camels aged between 6 and 10 years, camels from Gabra households and camels from larger herds of ⩾25 camels as important predictors of camel-level MERS-CoV seropositivity (Table 4 ).

In this survey, we describe the household demographic and socioeconomic factors, the livestock and camel herd profile and also highlight the determinants of individual and herd-level MERS-CoV seropositivity among camels in Northern Kenya. Overall, all herds sampled had seropositive camels, and animal-level seropositivity was associated with increasing age of camel (up to 10 years), large herd size (⩾25 camels) and ethnic community.

The herd-level and individual camel MERS-CoV seropositivity in the present study were comparable to the findings of previous studies in the same locality which used ELISA-based assays to detect MERS-CoV IgG antibodies in 74-90% of samples from Marsabit [2, 19, 27] . In a study of 85 camel herds from Northern Kenya by Munyua et al., the herd-level seropositivity was also 100% [19] . In a study of archived camel sera collected in Kenya between 1992 and 2013, the authors found higher exposure of camels to MERS-CoV that was associated with highly nomadic camels, while in a separate study of serum samples from nine camel herds in central Kenya, the authors found a much lower seroprevalence [2, 35] .

Although we did not assess MERS-CoV exposure among human subjects in contact with the camels, the finding of high seroprevalence among camels would imply high circulation of the virus in this environment and the potential for camel-to-human transmission, as has been shown in studies that have isolated MERS-CoV virus in this regions [27, 28] . However, the findings from previous studies in this region suggest minimal zoonotic transmission of the local MERS-CoV strain [19] . Still, the high seroprevalence in the area could point to the existence of unique drivers of transmission and maintenance of the virus among camels in this environment. The herd profile described here is diverse, comprising of large herds of mixed livestock species (average of 95 animals per household) with goats and camels forming the majority of animals in the herd. Households reared as many as five livestock species, including >75% of that owned three to five different species. This species diversification is deliberate, perhaps as an insurance against economic losses arising from recurrent droughts and devastating livestock disease outbreaks [36, 37] . Although different livestock species were reared together with the highly seropositive camels, we did not test sera from other livestock species for MERS-CoV IgG antibodies since they have been shown not to be susceptible to MERS-CoV infection in other studies [38] [39] [40] .

Almost 75% of the camels in the herds were adults (>2 years old), most reared as fora herds that resided as far as 150 km away from the homestead. The fora herds travelled up to 40 km daily in search of pastures and water and, in the process, mixed with other herds. These fora herds return to the original homestead during the rainy seasons when the pastures are plenty, and during communal celebrations. This rotational use of land is primarily designed to ensure effective use of pastures, help with pest and disease control, and to prevent inter-ethnic conflicts [41] . This planned pattern of camel movement over vast pasturelands, coupled with the introduction of up to 30% new camels annually, means a high rate of camel transition, and interaction between herds that may promote and sustain MERS-CoV infection and transmission within these herds. Studies have shown that MERS-CoV spreads between camels following contact with respiratory droplets or aerosolised virus from the faeces of infected camels [3, 4, 42, 43] .

We found more than threefold higher seroprevalence among older camels and those belonging to larger herd sizes (P < 0.001), characteristics more commonly in fora than home herds. Other studies have documented that MERS-CoV spreads more rapidly and efficiently in large herds, sometimes affecting the entire herd within a short period [44] . Larger camel herds are likely to offer a mix of infected camels that are shedding the virus and non-immune animals, creating an environment for a sustained transmission and maintenance of the virus [18, 45] . An important question that is not fully addressed is how long immunity to MERS-CoV lasts in camels, even though few studies suggest that the immunity may be short-lived [18] . We did not find any significant differences in the seroprevalence of anti-MERS-CoV antibodies between home and range camel herds (77.2% vs. 74.1%, P = 0.7). Despite being reared separately, these herds mixed frequently during communal ceremonies. Studies have demonstrated that differences in livestock production and management systems may affect the spread of infections [46, 47] .

In agreement with other studies, we documented a large proportion of calves 0-12 months of age with high neutralizing antibodies, suggesting the persistence of maternal antibodies [14, 18, 44] . The high seroprevalence observed in camels owned by the Gabra (>3-fold) and Rendille (>2-fold) communities may be explained by differences in camel herd structures and husbandry practices. We found female camels having higher seropositivity than males; however, this association reduced in magnitude in the multivariate model. It is likely that once maternally derived antibodies wane later in the first year of life, calves become infected repeatedly, thereby sustaining MERS-CoV infection in the herd and maybe infecting pregnant and lactating camels [18, 48, 49] .

Our study had a few limitations. The small number of herds (N = 29) in the survey limited our ability to draw further inferences on herd and community characteristics. Second, aspects of this study including specific risk factors for MERS-CoV transmission such as communal ceremonies (Sorrio) and human contact with camels could be better studied through mixed-methods studies. Our study used an MNT to determine the presence of anti-MERS-CoV antibodies in camel sera. An MNT was preferred for two reasons. First, the assay allowed for evaluation of the presence of functional antibodies in camel sera that recognise MERS-CoV and prevent infection in vitro. Second, the MNT effectively reduced non-specific binding and high positive signals in camels that have other cross-reacting antibodies (including antibodies to bovine coronaviruses), a challenge that may not have been easily overcome by most ELISA assays available to us [33] . However, it is possible that the neutralisation assay missed certain samples that produced non-neutralizing antibodies and those newly infected before the production of detectable levels of antibodies. A camel's seropositivity to anti-MERS-CoV antibodies indicates exposure and does not imply that the animal had active infections at the time of sampling, which may distort some of the associations observed.

Our study highlights the determinants of high MERS-CoV seropositivity in camels in the context of different camel husbandry practices (small vs. large herds, home vs. fora herds, young vs. older camels) in Northern Kenya, the knowledge that is needed in addressing the occupational risk of MERS-CoV among camel handlers. The MERS-CoV exposure profile depicted in our study suggests high transmission of the virus, primarily within the currently known reservoir camel population, underlining the need for camel vaccine to address potential human exposure. In the absence of alternative control strategies, it would be important to determine the duration of immunity in natural camel infections, as this could have a direct impact on the frequency and success of vaccination programmes in camels.

Supplementary material. The supplementary material for this article can be found at https://doi.org/10.1017/S0950268820002939.

Data. All data generated or analysed during this study are included in this published article and its supplemental files.

MERS coronavirus neutralizing antibodies in camels

Antibodies against MERS coronavirus in dromedary camels

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection

Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels

Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Geneva: World Health Organization

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus transmission

Middle East respiratory syndrome coronavirus seropositivity in camel handlers and their families

MERS-CoV infection among healthcare workers and risk factors for death: retrospective analysis of all laboratoryconfirmed cases reported to WHO from 2012 to 2

Serologic follow-up of Middle East respiratory syndrome coronavirus cases and contacts -Abu Dhabi

Asymptomatic Middle East respiratory syndrome coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review

MERS-CoV spillover at the camel-human interface

Middle East respiratory syndrome

The socio-economic implications of the coronavirus pandemic (COVID-19): a review

SARS: how a global epidemic was stopped

Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerging Microbes and Infections 6

No serologic evidence of Middle East respiratory syndrome coronavirus infection among camel farmers exposed to highly seropositive camel herds: a household linked study

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia

MERS and the dromedary camel trade between Africa and the Middle East

Food and Agriculture Organization Statistics, FAOSTATS|Live Animals

Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction

Middle East respiratory syndrome-coronavirus in camels: an overview for Sub-Saharan and North Africa

World Health Organization (2019) International Clinical Trials Registry Platform. Geneva: World Health Organization

Mapping potential amplification and transmission hotspots for MERS-CoV

Genetic evidence of Middle East respiratory syndrome coronavirus (MERS-Cov) and widespread seroprevalence among Camels in Kenya

Detection of distinct MERS-coronavirus strains in dromedary camels from Kenya

QGIS Geographic Information System, Open Source Geospatial Foundation Project

Marsabit County Integrated Development Plan

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description

The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

Serological evidence of MERS-CoV antibodies in dromedary camels (Camelus dromedaries) in Laikipia county

Livestock diversification: an adaptive strategy to climate and rangeland ecosystem changes in Southern Ethiopia

The role of livestock diversification in ensuring household food security under a changing climate in Borana

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan

Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia

Camel husbandry practices in Eastern Ethiopia: the case of Jujiga and Shinile zones

Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications

Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions

Time course of MERS-CoV infection and immunity in dromedary camels

Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels

Strong association between human and animal Brucella seropositivity in a linked study in Kenya

Zoonotic pathogen seroprevalence in cattle in a wildlife-livestock interface

MERS coronavirus in dromedary camel herd, Saudi Arabia

Longitudinal study of Middle East respiratory syndrome coronavirus infection in dromedary camel herds in Saudi Arabia

Acknowledgements. We thank Dr Arithi Mutembei, Diba Denge, Boru Dub Wato, Millicent Minayo, Richard Karuti, Dr Eunice Omondi, Moshe Alando, Cynthia Awuor and James Akoko for their contribution during household visits and camel sampling. We appreciate the camel keepers in Marsabit who participated in the survey and Veterinary Department, Marsabit County for allowing us to use their laboratory facility located in Marsabit for short-term sample storage, sera extraction and logistics coordination. We thank the scientific and administrative team at the Washington State University Global Health Program involved in the project for their diligence and untiring efforts. 

Ethical standards. This study was reviewed and approved by the KEMRI Scientific and Ethical Review Committee (approval number SSC3472), Washington State University human and animal ethical committee (approval numbers 16245 and 6124) and by US Centers for Disease Control and Prevention. Administrative approvals were obtained from the Kenya Ministry of Health, Kenya Ministry of Agriculture, Livestock and Fisheries, and Marsabit county government. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all camel owners and animal handlers prior to the questionnaire interview or sampling. All applicable institutional and national guidelines for the care and use of animals were strictly followed in the conduct of this study.